Nurix Therapeutics, Inc. NRIX Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s operating income?
- Nurix Therapeutics, Inc. (NRIX) reported operating income of -$92.5M in Q4 2025.
- How has Nurix Therapeutics, Inc.'s operating income changed year-over-year?
- Nurix Therapeutics, Inc.'s operating income decreased by 47.1% year-over-year, from -$62.86M to -$92.5M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s operating income?
- Over 4 years (2021 to 2025), Nurix Therapeutics, Inc.'s operating income has grown at a 24.8% compound annual growth rate (CAGR), from -$117.89M to -$285.67M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.